Caution on LRP4 antibody results in patients being evaluated for myasthenia gravis
- PMID: 36924656
- DOI: 10.1016/j.jneuroim.2023.578063
Caution on LRP4 antibody results in patients being evaluated for myasthenia gravis
Keywords: LRP4 antibody; Myasthenia gravis.
Conflict of interest statement
Declaration of Competing Interest Dr. Heber has no declaration of interest. Dr. Li has consulted for Argenx, Catalyst, Immunovant and UCB Pharma, and has received grant support from Argenx.
Comment on
-
LRP4-IgG service line testing in seronegative myasthenia gravis and controls.J Neuroimmunol. 2022 Jul 15;368:577895. doi: 10.1016/j.jneuroim.2022.577895. Epub 2022 May 18. J Neuroimmunol. 2022. PMID: 35617719
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous